SCHEMBL6944893

SCHEMBL6944893

COC(Cc1ccc2ccncc2c1)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.48
TBXAS1 P24557 1/20 0.48
AKT1 P31749 2/20 0.43
MELK Q14680 2/20 0.40
PRKCZ Q05513 1/20 0.40
PDE10A Q9Y233 3/20 0.39
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
IKBKB O14920 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18417279 0.83 CYP19A1 (0.50) CYP19A1TBXAS1AKT1MELKPRKCZ
SCHEMBL30824478 0.79 CYP19A1 (0.50) CYP19A1TBXAS1MELKPRKCZPDE10A
SCHEMBL3144610 0.79 CYP19A1 (0.50) CYP19A1TBXAS1MELKPRKCZPDE10A
SCHEMBL6114863 0.77 CYP1A2 (0.55) CYP19A1TBXAS1MELKPRKCZPDE10A
SCHEMBL30286452 0.76 CYP19A1 (0.50) CYP19A1TBXAS1AKT1PDE10AHTR2A
SCHEMBL18417282 0.76 CYP19A1 (0.50) CYP19A1TBXAS1AKT1PDE10AHTR2A
SCHEMBL6114835 0.74 CYP19A1 (0.51) CYP19A1TBXAS1MELKPRKCZMEN1
SCHEMBL11142351 0.73 CYP19A1 (0.48) CYP19A1TBXAS1AKT1PDE10AHTR2A
SCHEMBL30896286 0.73 CYP19A1 (0.54) CYP19A1TBXAS1AKT1MELKPRKCZ
SCHEMBL5779124 0.73 MELK (0.55) CYP19A1TBXAS1AKT1MELKPRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6509351-B1 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation SANOFI-SYNTELABO (FR) 2003-01-21 US disclosed